| Identification | Back Directory | [Name]
Thiourea, N-[2-(3,5-dibromo-2-hydroxyphenyl)ethenyl]-N'-(3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl)- | [CAS]
1005288-15-2 | [Synonyms]
β-catenin-IN-3
β-catenin inhibitor C2
Thiourea, N-[2-(3,5-dibromo-2-hydroxyphenyl)ethenyl]-N'-(3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl)- | [Molecular Formula]
C19H20Br2N2OS | [MOL File]
1005288-15-2.mol | [Molecular Weight]
484.25 |
| Chemical Properties | Back Directory | [Boiling point ]
539.4±60.0 °C(Predicted) | [density ]
1.73±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
7.56±0.50(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
β-catenin-IN-3 (Compound C2) is a selective β-catenin inhibitor. β-catenin-IN-3 binds to allosteric site on the surface of β-catenin with K D calculated at 54.96 nM. β-catenin-IN-3 selectively inhibits β-catenin via targeting a cryptic allosteric modulation site, lowers its cellular load. β-catenin-IN-3 significantly reduces viability of β-catenin driven cancer cells, and triggers β-catenin degradation via proteasome system in β-catenin-overexpressing cancer cells[1]. | [in vivo]
β-catenin-IN-3 (25 mg/kg, i.p., 35 days) notably reduces β-catenin-dependent tumor growth represented in DLD1 xenograft model[1].
| Animal Model: | 6-week-old female NSG (NOD-SCID) mice were injected with 3 *106 DLD1 cells[1]. | | Dosage: | 25 mg/kg | | Administration: | i.p., 35 days | | Result: | Mice Did not display any signs of acute toxicity and body weight loss.
Inhibition of tumor growth by β-catenin-IN-3 was noted after 20 days of treatment, after which the tumor volume of β-catenin-IN-3 treated mice did not increase exponentially.
At day 35, the calculated tumor growth inhibition by β-catenin-IN-3 was 50% as compared to the vehicle.
|
| [IC 50]
Cdk4/cyclin D1 | [References]
[1] Cheltsov A, et al. Allosteric inhibitor of β-catenin selectively targets oncogenic Wnt signaling in colon cancer. Sci Rep. 2020;10(1):8096. Published 2020 May 15. DOI:10.1038/s41598-020-60784-y |
|
|